... 350,000 shares he had bought for just $400 in a shell company that did a reverse merger with a drug company, Retrophin, that Shkreli had founded.
Growth Capitalist (https://growthcapitalist.com/2017/07/stock-trader-didnt-see-martin-shkreli-doing-much-stock-trading-while-running-hedge-funds/)
... 350,000 shares he had bought for just $400 in a shell company that did a reverse merger with a drug company, Retrophin, that Shkreli had founded.